Cargando…

Insights into metabolic and pharmacological profiling of Aspergillus ficuum through bioinformatics and experimental techniques

BACKGROUND: Recently, numerous novel bioactive fungal metabolites have been identified that possess broad therapeutic activities including anti-inflammatory, antibiotic, antioxidant, and antitumor. The fungal mycochemicals as well as extracts have increased the interest of the scientific community i...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Zafar Ali, Khan, Khalid, Rashid, Haroon Ur, Shah, Tanzeel, Jaremko, Mariusz, Iqbal, Zafar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733250/
https://www.ncbi.nlm.nih.gov/pubmed/36482311
http://dx.doi.org/10.1186/s12866-022-02693-w
_version_ 1784846327857807360
author Shah, Zafar Ali
Khan, Khalid
Rashid, Haroon Ur
Shah, Tanzeel
Jaremko, Mariusz
Iqbal, Zafar
author_facet Shah, Zafar Ali
Khan, Khalid
Rashid, Haroon Ur
Shah, Tanzeel
Jaremko, Mariusz
Iqbal, Zafar
author_sort Shah, Zafar Ali
collection PubMed
description BACKGROUND: Recently, numerous novel bioactive fungal metabolites have been identified that possess broad therapeutic activities including anti-inflammatory, antibiotic, antioxidant, and antitumor. The fungal mycochemicals as well as extracts have increased the interest of the scientific community in drug discovery research through a combination approach such as, molecular metabolic, pharmacological and computational techniques. Therefore, the natural fungus Aspergillus ficuum (A. ficuum) (FCBP-DNA-1266) was selected for metabolic and pharmacological profiling in this study. RESULTS: The metabolic profile of A. ficuum was explored for the first time and revealed the presence of bioactive compounds such as choline sulfate, noruron, hydroxyvittatine, aurasperone D, cetrimonium, kurilensoside, heneicosane, nonadecane and eicosane. Similarly, a pharmacological screen of A. ficuum was performed for the first time in in vivo and in vitro models. Interestingly, both the ethyl acetate and n-hexane fractions of A. ficuum were found to be more active against Bacillus subtilis among five tested bacteria with their zone of inhibition (ZOI) values of 21.00 mm ±1.00 and 23.00 mm ±1.00, at a concentration of 150 μgmL(-1) respectively. Similarly, a significant decrease (P<0.001) and (P<0.01) in paw edema was observed in A. ficuum-treated animals at doses of 50 and 150 mgkg(-1), respectively, reflecting its potent anti-inflammatory effect. Furthermore, the docking results supported the antibacterial and anti-inflammatory effects of A. ficuum. In addition, the crude extract demonstrated no acute toxicity and the highest percent radical scavenging was recorded for both n-hexane and ethyl acetate extracts. CONCLUSION: The metabolic profile of A. ficuum indicated the presence of biological relevant compounds. A. ficuum extract exhibited potent antibacterial and anti-inflammatory effects supported by docking results. Furthermore, A. ficuum extract demonstrated the highest percentage of radical scavenging activity along with no acute toxicity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12866-022-02693-w.
format Online
Article
Text
id pubmed-9733250
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97332502022-12-10 Insights into metabolic and pharmacological profiling of Aspergillus ficuum through bioinformatics and experimental techniques Shah, Zafar Ali Khan, Khalid Rashid, Haroon Ur Shah, Tanzeel Jaremko, Mariusz Iqbal, Zafar BMC Microbiol Research BACKGROUND: Recently, numerous novel bioactive fungal metabolites have been identified that possess broad therapeutic activities including anti-inflammatory, antibiotic, antioxidant, and antitumor. The fungal mycochemicals as well as extracts have increased the interest of the scientific community in drug discovery research through a combination approach such as, molecular metabolic, pharmacological and computational techniques. Therefore, the natural fungus Aspergillus ficuum (A. ficuum) (FCBP-DNA-1266) was selected for metabolic and pharmacological profiling in this study. RESULTS: The metabolic profile of A. ficuum was explored for the first time and revealed the presence of bioactive compounds such as choline sulfate, noruron, hydroxyvittatine, aurasperone D, cetrimonium, kurilensoside, heneicosane, nonadecane and eicosane. Similarly, a pharmacological screen of A. ficuum was performed for the first time in in vivo and in vitro models. Interestingly, both the ethyl acetate and n-hexane fractions of A. ficuum were found to be more active against Bacillus subtilis among five tested bacteria with their zone of inhibition (ZOI) values of 21.00 mm ±1.00 and 23.00 mm ±1.00, at a concentration of 150 μgmL(-1) respectively. Similarly, a significant decrease (P<0.001) and (P<0.01) in paw edema was observed in A. ficuum-treated animals at doses of 50 and 150 mgkg(-1), respectively, reflecting its potent anti-inflammatory effect. Furthermore, the docking results supported the antibacterial and anti-inflammatory effects of A. ficuum. In addition, the crude extract demonstrated no acute toxicity and the highest percent radical scavenging was recorded for both n-hexane and ethyl acetate extracts. CONCLUSION: The metabolic profile of A. ficuum indicated the presence of biological relevant compounds. A. ficuum extract exhibited potent antibacterial and anti-inflammatory effects supported by docking results. Furthermore, A. ficuum extract demonstrated the highest percentage of radical scavenging activity along with no acute toxicity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12866-022-02693-w. BioMed Central 2022-12-09 /pmc/articles/PMC9733250/ /pubmed/36482311 http://dx.doi.org/10.1186/s12866-022-02693-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Shah, Zafar Ali
Khan, Khalid
Rashid, Haroon Ur
Shah, Tanzeel
Jaremko, Mariusz
Iqbal, Zafar
Insights into metabolic and pharmacological profiling of Aspergillus ficuum through bioinformatics and experimental techniques
title Insights into metabolic and pharmacological profiling of Aspergillus ficuum through bioinformatics and experimental techniques
title_full Insights into metabolic and pharmacological profiling of Aspergillus ficuum through bioinformatics and experimental techniques
title_fullStr Insights into metabolic and pharmacological profiling of Aspergillus ficuum through bioinformatics and experimental techniques
title_full_unstemmed Insights into metabolic and pharmacological profiling of Aspergillus ficuum through bioinformatics and experimental techniques
title_short Insights into metabolic and pharmacological profiling of Aspergillus ficuum through bioinformatics and experimental techniques
title_sort insights into metabolic and pharmacological profiling of aspergillus ficuum through bioinformatics and experimental techniques
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733250/
https://www.ncbi.nlm.nih.gov/pubmed/36482311
http://dx.doi.org/10.1186/s12866-022-02693-w
work_keys_str_mv AT shahzafarali insightsintometabolicandpharmacologicalprofilingofaspergillusficuumthroughbioinformaticsandexperimentaltechniques
AT khankhalid insightsintometabolicandpharmacologicalprofilingofaspergillusficuumthroughbioinformaticsandexperimentaltechniques
AT rashidharoonur insightsintometabolicandpharmacologicalprofilingofaspergillusficuumthroughbioinformaticsandexperimentaltechniques
AT shahtanzeel insightsintometabolicandpharmacologicalprofilingofaspergillusficuumthroughbioinformaticsandexperimentaltechniques
AT jaremkomariusz insightsintometabolicandpharmacologicalprofilingofaspergillusficuumthroughbioinformaticsandexperimentaltechniques
AT iqbalzafar insightsintometabolicandpharmacologicalprofilingofaspergillusficuumthroughbioinformaticsandexperimentaltechniques